Ebola surge in Uganda underscores need for stronger cross‑border health surveillance
The outbreak highlights gaps in cross‑border health surveillance under the Integrated Disease Surveillance Programme and the WHO International Health Regulations. It also underscores the market failure in developing vaccines for rare but high‑impact diseases, a recurring theme in public‑health policy.
GS 3 (Health) – candidates can discuss strengthening cross‑border surveillance and addressing vaccine market failures. A likely question may ask to evaluate the response mechanisms for trans‑national disease outbreaks.
Ebola virus disease outbreak
Cross‑border health surveillance
Vaccine research and market failure
Ebola surge in Uganda underscores need for stronger cross‑border health surveillance
The outbreak highlights gaps in cross‑border health surveillance under the Integrated Disease Surveillance Programme and the WHO International Health Regulations. It also underscores the market failure in developing vaccines for rare but high‑impact diseases, a recurring theme in public‑health policy.
GS 3 (Health) – candidates can discuss strengthening cross‑border surveillance and addressing vaccine market failures. A likely question may ask to evaluate the response mechanisms for trans‑national disease outbreaks.